CSE

The Company is a pharmaceutical company focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. The Company intends to do this through the development of compounds with known activity and/or safety profiles. The Company’s lead program is designed to address neurological disorders through the therapeutic dosing of synthetic psilocybin.

Pampa Metals Corp. (“Pampa Metals”) is a Canadian company listed on the Canadian Securities Exchange (CSE: PM). Pampa Metals holds a portfolio of eight exploration properties totalling 58,000 hectares prospective for copper and gold located along proven mineral belts in Chile, one of the world's top mining jurisdictions.

The Company is engaged in the business of mineral exploration with a focus on precious metals. The Company’s current objective is to explore and, if warranted, develop the Green Mountain Property, an exploration stage gold property located in Osoyoos Mining District in the Province of British Columbia, Canada.

The Issuer is a junior mining exploration company. Its current focus is to conduct the proposed exploration program on the Pichogen Property, as more particularly set out in the Technical Report, along with continuing to identify and potentially acquire additional property interests, assess their potential and engage in exploration activities.